Tofacitinib in Juvenile Idiopathic Arthritis

NCT07211932 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

58

Enrollment

OTHER

Sponsor class

Conditions

Juvenile Idiopathic Arthritis (JIA)

Interventions

DRUG: Tofacitinib

Sponsor

Consorci Sanitari de l'Alt Penedès i Garraf